Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten A Karsdal

Showing results (1-10 of 341) with videos related to

Pageof 35
Sort By:
Nature Biomedical Engineering|May 13, 2020
Supramolecularly stabilized diabetes drugsKim Henriksen, Morten A Karsdal
Calcified Tissue International|May 6, 2020
Osteoarthritis: Current Molecular Biomarkers and the Way ForwardVirginia Byers Kraus, Morten A Karsdal
American Journal of Translational Research|February 8, 2013
Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker developmentEfstathios Vassiliadis, Natasha Barascuk, Morten A Karsdal
Scientific Reports|June 12, 2026
Collagen-derived biomarkers reveal distinct fibrotic responses among cancer-associated fibroblastsAnnika Hettich, Morten A Karsdal, Nicholas Willumsen
Expert Review of Endocrinology & Metabolism|October 7, 2018
A comparison of strontium ranelate and PTH(1-84)Kim Henriksen, Claus Christiansen, Morten A Karsdal
Translational Oncology|March 12, 2019
Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer - A Proof of Concept StudyNicholas Willumsen, Cecilie Bager, Morten A Karsdal
Women'S Health (London, England)|October 30, 2009
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?Peter Alexandersen, Morten A Karsdal, Claus Christiansen
Molecular Metabolism|November 9, 2020
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseasesNina Sonne, Morten A Karsdal, Kim Henriksen
Plos One|June 20, 2020
The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional studyDitte S Jonesco, Morten A Karsdal, Kim Henriksen
European Journal of Pharmacology|June 17, 2023
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight lossAnna Thorsø Larsen, Morten A Karsdal, Kim Henriksen
Pageof 35

Showing results (1-10 of 341) with videos related to

Sort By:
Pageof 35
Nature Biomedical Engineering|May 13, 2020
Supramolecularly stabilized diabetes drugsKim Henriksen, Morten A Karsdal
Calcified Tissue International|May 6, 2020
Osteoarthritis: Current Molecular Biomarkers and the Way ForwardVirginia Byers Kraus, Morten A Karsdal
American Journal of Translational Research|February 8, 2013
Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker developmentEfstathios Vassiliadis, Natasha Barascuk, Morten A Karsdal
Scientific Reports|June 12, 2026
Collagen-derived biomarkers reveal distinct fibrotic responses among cancer-associated fibroblastsAnnika Hettich, Morten A Karsdal, Nicholas Willumsen
Expert Review of Endocrinology & Metabolism|October 7, 2018
A comparison of strontium ranelate and PTH(1-84)Kim Henriksen, Claus Christiansen, Morten A Karsdal
Translational Oncology|March 12, 2019
Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer - A Proof of Concept StudyNicholas Willumsen, Cecilie Bager, Morten A Karsdal
Women'S Health (London, England)|October 30, 2009
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?Peter Alexandersen, Morten A Karsdal, Claus Christiansen
Molecular Metabolism|November 9, 2020
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseasesNina Sonne, Morten A Karsdal, Kim Henriksen
Plos One|June 20, 2020
The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional studyDitte S Jonesco, Morten A Karsdal, Kim Henriksen
European Journal of Pharmacology|June 17, 2023
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight lossAnna Thorsø Larsen, Morten A Karsdal, Kim Henriksen
Pageof 35